Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Paroxetine hydrochloride hemihydrate
Drug ID BADD_D01681
Description Paroxetine is a selective serotonin reuptake inhibitor (SSRI) drug commonly known as Paxil. It has a variety of uses, including the treatment of anxiety disorders, major depression, posttraumatic stress disorder, and symptoms of menopause, among others.[T653] It was approved by the FDA in the early 1990s and marketed by SmithKline Beecham.[L7712,L7715] A unique feature of this drug is that it is highly potent and selective in its inhibition of serotonin reuptake and has little effect on other neurotransmitters.[A31914] Because of its potent inhibition of serotonin reuptake, paroxetine is more likely to cause withdrawal effects upon cessation. Paroxetine is well tolerated in most patients with a similar adverse effect profile to other members of its drug class.[A31914] The controlled release formulation was designed to decrease the likelihood of nausea that is sometimes associated with paroxetine.[L7700,L7742]
Indications and Usage Paroxetine is indicated for the management of depression, obsessive-compulsive disorder, panic disorder, social anxiety disorder, generalized anxiety disorder, posttraumatic stress disorder.[L3358] One form of paroxetine, commercially known as Brisdelle, is used to manage mild to moderate vasomotor symptoms of menopause.[L7703] Off-label, paroxetine may be used for the treatment of premature ejaculation or irritable bowel syndrome (IBS).[A1093,A181754,A181904]
Marketing Status approved; investigational
ATC Code N06AB05
DrugBank ID DB00715
KEGG ID D02260
MeSH ID D017374
PubChem ID 9843029
TTD Drug ID D06GDY
NDC Product Code 42858-705; 70518-1253; 71610-243; 42858-707; 63629-9498; 70518-0550; 73377-051; 70518-2376; 43547-348; 55700-503; 63187-927; 70518-2387; 43353-544; 55289-053; 63629-9499; 63629-9500; 0378-7003; 0378-7004; 70518-1406; 53296-0057; 42858-703; 43547-349; 50090-5987; 71205-527; 71610-204; 0615-7985; 62350-0044; 43353-554; 43547-350; 0378-7001; 0378-7002; 70518-2182; 70518-2598; 64220-113; 55289-037; 71205-198; 43547-347
UNII 41VRH5220H
Synonyms Paroxetine | Aropax | BRL-29060 | BRL 29060 | BRL29060 | FG-7051 | FG 7051 | FG7051 | Paroxetine Acetate | Seroxat | Paroxetine Hydrochloride Anhydrous | Paroxetine Maleate | Paroxetine, cis-(+)-Isomer | Paroxetine, cis-(-)-Isomer | Paroxetine, trans-(+)-Isomer | Paxil | Paroxetine Hydrochloride Hemihydrate | Paroxetine Hydrochloride, Hemihydrate | Paroxetine Hydrochloride
Chemical Information
Molecular Formula C19H23ClFNO4
CAS Registry Number 110429-35-1
SMILES C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4.O.Cl
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Duodenitis07.08.03.001--Not Available
Dysarthria19.19.03.001; 17.02.08.001--
Dysgeusia17.02.07.003; 07.14.03.001--
Dyskinesia17.01.02.006--
Dysmenorrhoea21.01.01.002--
Dyspepsia07.01.02.001--
Dysphagia07.01.06.003--
Dysphonia22.12.03.006; 17.02.08.004; 19.19.03.002--
Dyspnoea02.11.05.003; 22.02.01.004--
Dystonia17.01.03.001--Not Available
Dysuria20.02.02.002--
Ear pain04.03.01.003--
Ecchymosis24.07.06.002; 23.06.01.001; 01.01.03.001--Not Available
Eclampsia20.01.08.001; 18.02.03.001; 17.12.03.012; 24.08.07.001--Not Available
Eczema23.03.04.006--
Ejaculation disorder21.03.01.002--
Emotional poverty19.04.02.015--Not Available
Emphysema22.01.02.002--Not Available
Endometrial disorder21.07.01.001--Not Available
Enteritis07.08.03.002--
Eosinophilia01.02.04.001--
Epididymitis21.09.02.001; 11.01.19.005--Not Available
Epistaxis24.07.01.005; 22.04.03.001--
Eructation07.01.02.003--
Erythema multiforme10.01.03.015; 23.03.01.003--
Erythema nodosum10.02.01.020; 23.07.02.001--Not Available
Euphoric mood19.04.02.006--
Exophthalmos06.09.04.001; 05.02.02.002--Not Available
Extrapyramidal disorder17.01.02.007--
Eye haemorrhage12.02.02.012; 24.07.05.002; 06.07.02.001--Not Available
The 4th Page    First    Pre   4 5 6 7 8    Next   Last    Total 13 Pages